A Novel Two-Lipid Signature Is a Strong and Independent Prognostic Factor in Ovarian Cancer.
Salminen L, Braicu EI, Lääperi M, Jylhä A, Oksa S, Hietanen S, Sehouli J, Kulbe H, Bois AD, Mahner S, Harter P, Carpén O, Huhtinen K, Hynninen J, Hilvo M.
Salminen L, et al. Among authors: oksa s.
Cancers (Basel). 2021 Apr 7;13(8):1764. doi: 10.3390/cancers13081764.
Cancers (Basel). 2021.
PMID: 33917079
Free PMC article.